Evidence map›Paper›PMID 33806187›Full record

ArticleMolecules (Basel, Switzerland)2021

Comparison of Multiple Bioactive Constituents in the Corolla and Other Parts of

Shengxin Yin, Yuqi Mei, Lifang Wei, Lisi Zou, Zhichen Cai, Nan Wu, Jiahuan Yuan, Xunhong Liu, Haitao Ge, Dianguang Wang and 1 more

Abstract readComparative Study
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Therapeutic potential ofFrontiers in pharmacology · 2025
    Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shengxin YinCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Yuqi MeiCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Lifang WeiCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Lisi ZouCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Zhichen CaiCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.ORCID 0000-0002-0911-5934
Nan WuCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Jiahuan YuanCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Xunhong LiuCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Haitao GeSZYY Group Pharmaceutical Limited, Taizhou 225500, China.
Dianguang WangSZYY Group Pharmaceutical Limited, Taizhou 225500, China.
Dandan WangSZYY Group Pharmaceutical Limited, Taizhou 225500, China.

Funding

Standardization of Chinese Materia Medica Program ZYBZH-C-JS-32
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AbelmoschusChromatography, High Pressure LiquidMass SpectrometryPhytochemicalsPlant ExtractsPlant LeavesPhytochemicalsPlant ExtractsAbelmoschus manihotbioactive constituentscorolladistribution patternsleafrootseedstem

Identifiers

PMID33806187
PMCPMC8037085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.